Background: Benign stenosis involving laryngeal and upper tracheal structures represents a therapeutic challenge. Open surgery and endoscopic management have to be discussed by a multidisciplinary board in order to evaluate the risk and benefit for each patient. Objective: The objective of this retrospective study was to report the experience of two French centers with transcordal silicone stents (TSS) in the endoscopic management of benign laryngotracheal stenosis (BLTS) in adults, with focus on efficacy, safety, and tolerability. Methods: We performed a retrospective chart review of all cases of BLTS treated with TSS between January 2001 and June 2017 at two tertiary centers in France: the Centre Hospitalier Régional Universitaire de Strasbourg and the Hôpital Nord de Marseille. Results: A total of 17 patients were included. Eleven had a tracheostomy at initial management which consisted of 8 T-tubes and 9 strictly endoluminal stents placements. The main complications were minor aspirations in 5 patients (29%), granulation in 3 patients (18%), migration in 2 patients (12%), and severe dysphonia in 3 patients (18%). After a mean duration of 18.3 months, 11 patients (65%) had had their TSS definitely removed, 13 patients were tracheostomy free (76%), and a TSS remained in place in 4 patients (24%). Conclusions: Adult BLTS treatment with TSS placement is associated with low morbidity and excellent clinical outcomes, with a large proportion of patients free of airway instrumentation on long-term follow-up.

Keywords:
Airway stenting, Benign laryngotracheal stenosis, Silicone stents, Therapeutic bronchoscopy
1.
Lorenz RR: Adult laryngotracheal stenosis: etiology and surgical management. Curr Opin Otolaryngol Head Neck Surg 2003; 11: 467–472.
2.
Anand VK, Alemar G, Warren ET: Surgical considerations in tracheal stenosis. Laryngoscope 1992; 102: 237–243.
3.
Grillo HC, Donahue DM, Mathisen DJ, et al: Postintubation tracheal stenosis. Treatment and results. J Thorac Cardiovasc Surg 1995; 109: 486–492.
4.
París F, Borro JM, Tarrazona V, et al: Management of non-tumoral tracheal stenosis in 112 patients. Eur J Cardiothorac Surg 1990; 4: 265–268; discussion 268–269.
5.
Maggi G, Ardissone F, Cavallo A, et al: Tracheal stenosis. A study of 100 cases. Int Surg 1990; 75: 225–230.
6.
Bonnette P, Colchen A, Leroy M, et al: Tracheal resection-anastomosis for iatrogenic stenosis. Experience in 340 cases. Rev Mal Respir 1998; 15: 627–632.
7.
Rea F, Callegaro D, Loy M, et al: Benign tracheal and laryngotracheal stenosis: surgical treatment and results. Eur J Cardiothorac Surg 2002; 22: 352–356.
8.
Dalar L, Karasulu L, Abul Y, et al: Bronchoscopic treatment in the management of benign tracheal stenosis: choices for simple and complex tracheal stenosis. Ann Thorac Surg 2016; 10: 1310–1317.
9.
Galluccio G, Lucantoni G, Battistoni P, et al: Interventional endoscopy in the management of benign tracheal stenoses: definitive treatment at long-term follow-up. Eur J Cardiothorac Surg 2009; 35: 429–433.
10.
Brichet A, Verkindre C, Dupont J, et al: Multidisciplinary approach to management of postintubation tracheal stenoses. Eur Respir J 1999; 13: 888–893.
11.
Cavaliere S, Bezzi M, Toninelli C, et al: Management of post-intubation tracheal stenoses using the endoscopic approach. Monaldi Arch Chest Dis 2007; 67: 73–80.
12.
Martinez-Ballarin JI, Diaz-Jimenez JP, Castro MJ, et al: Silicone stents in the management of benign tracheobronchial stenoses. Tolerance and early results in 63 patients. Chest 1996; 109: 626–629.
13.
Maldonado F, Loiselle A, Depew ZS, et al: Idiopathic subglottic stenosis: an evolving therapeutic algorithm. Laryngoscope 2014; 124: 498–503.
14.
Bolliger CT, Probst R, Tschopp K, et al: Silicone stents in the management of inoperable tracheobronchial stenosis: indications and limitations. Chest 1993; 104: 1653–1659.
15.
Fortin M, Lacasse Y, Elharrar X, et al: Safety and efficacy of a fully covered self-expandable metallic stent in benign airway stenosis. Respiration 2017; 93: 430–435.
16.
D’Andrilli A, Venuta F, Rendina EA: Sub-glottic tracheal stenosis. J Thorac Dis 2016; 8 (suppl 2):S140–S147.
17.
Monnier P: A new stent for the management of adult and pediatric laryngotracheal stenosis. Laryngoscope 2003; 113: 1418–1422.
18.
Chambres O, Schultz P, Debry C: The Larynxane ST intralaryngeal endoprosthesis for laryngotracheal pathologies. J Laryngol Otol 2006; 120: 942–948.
19.
Alshammari J, Monnier P: Airway stenting with the LT-MoldTM for severe glotto-subglottic stenosis or intractable aspiration: experience in 65 cases. Eur Arch Otorhinolaryngol 2012; 269: 2531–2538.
20.
George M, Lang F, Pasche P, et al: Surgical management of laryngotracheal stenosis in adults. Eur Arch Otorhinolaryngol 2005; 262: 609–615.
21.
Rubikas R, Matukaitytė I, Jelisiejevas JJ, et al: Surgical treatment of non-malignant laryngotracheal stenosis. Eur Arch Otorhinolaryngol 2014; 271: 2481–2487.
22.
Lewis S, Earley M, Rosenfeld R, et al: Systematic review for surgical treatment of adult and adolescent laryngotracheal stenosis. Laryngoscope 2017; 127: 191–198.
23.
Gadkaree SK, Pandian V, Best S, et al: Laryngotracheal stenosis: risk factors for tracheostomy dependence and dilation interval. Otolaryngol Head Neck Surg 2017; 156: 321–328.
24.
Sandu K, Monnier P: Cricotracheal resection. Otolaryngol Clin North Am 2008; 41: 981–998.
25.
Myer CM, O’Connor DM, Cotton RT: Proposed grading system for subglottic stenosis based on endotracheal tube sizes. Ann Otol Rhinol Laryngol 1994; 103: 319–323.
26.
Pradhan T, Kapil S, Thakar A: Posterior cricoid split with costal cartilage augmentation for high subglottic stenosis. Indian J Otolaryngol Head Neck Surg 2008; 60: 147–151.
27.
Keghian J, Lawson G, Orban D, et al: Composite hyoid-sternohyoid interposition graft in the surgical treatment of laryngotracheal stenosis. Eur Arch Otorhinolaryngol 2000; 257: 542–547.
28.
Baujat B, Struk S, Lesnik M, et al: Fascia temporalis free flap for cricotracheal reconstruction: a novel approach. Ann Thorac Surg 2017; 104: 1040–1046.
29.
Naunheim MR, Song PC, Franco RA, et al: Surgical management of bilateral vocal fold paralysis: a cost-effectiveness comparison of two treatments. Laryngoscope 2017; 127: 691–697.
30.
Ciccone AM, De Giacomo T, Venuta F, et al: Operative and non-operative treatment of benign subglottic laryngotracheal stenosis. Eur J Cardiothorac Surg 2004; 26: 818–822.
31.
Eliashar R, Gross M, Maly B, et al: Mitomycin does not prevent laryngotracheal repeat stenosis after endoscopic dilation surgery: an animal study. Laryngoscope 2004; 114: 743–746.
32.
Perepelitsyn I, Shapshay SM: Endoscopic treatment of laryngeal and tracheal steno sis – has mitomycin C improved the outcome? Otolaryngol Head Neck Surg 2004; 131: 16–20.
33.
Colt HG, Harrell J, Neuman TR, et al: External fixation of subglottic tracheal stents. Chest 1994; 105: 1653–1657.
34.
Miwa K, Takamori S, Hayashi A, et al: Fixation of silicone stents in the subglottic trachea: preventing stent migration using a fixation apparatus. Ann Thorac Surg 2004; 78: 2188–2190.
35.
Majid A, Fernandez-Bussy S, Kent M, et al: External fixation of proximal tracheal airway stents: a modified technique. Ann Thorac Surg 2012; 93:e167–e169.
36.
Musani AI, Jensen K, Mitchell JD, et al: Novel use of a percutaneous endoscopic gastrostomy tube fastener for securing silicone tracheal stents in patients with benign proximal airway obstruction. J Bronchology Interv Pul-monol 2012; 19: 121–125.
37.
Dhooria S, Agarwal R: External fixation of a subglottic tracheal silicone stent. Ann Am Thorac Soc 2014; 11: 467–468.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.